Suppression of G6PD blocks EMT of OSCC cell lines and reduces lymphatic metastasis in OSCC orthotopic xenograft model, which indicates that targeting G6PD in cancer cells could be an effective therapeutic strategy. The gene discussed is G6PD; the disease is cancer.